Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
The Journal of Investigative Dermatology
|
June 20, 2008
B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses
Hugo Mouquet, Philippe Musette, Marie-Lyse Gougeon, et al.
Transfusion
|
September 4, 2007
Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature
Justyna Kanold, Etienne Merlin, Pascale Halle, et al.
Experimental Dermatology
|
September 3, 2025
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model
Marine Delmas, Benjamin Chaussin, Nathan Harismendy, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 25, 2002
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging
Nicole Moins, Michel D'Incan, Jacques Bonafous, et al.
European Journal of Dermatology : EJD
|
December 31, 2014
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models
Claire Viallard, Yann Perrot, Zied Boudhraa, et al.
Journal of the American Academy of Dermatology
|
January 29, 2022
Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study
Gilles Battesti, Charline Garcia, Manuelle Viguier, et al.
BMC Cancer
|
April 16, 2022
Phase I study of [<sup>131</sup>I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
Emilie Thivat, Jacques Rouanet, Philippe Auzeloux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2010
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients
Delphine Kérob, Raphael Porcher, Olivier Vérola, et al.
Archives of Dermatology
|
June 19, 2008
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome
Gaëlle Quereux, Sonia Marques, Jean-Michel Nguyen, et al.
American Journal of Clinical Pathology
|
January 14, 2011
Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases
Claire Bénet, Aurélie Gomez, Claire Aguilar, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
The Journal of Investigative Dermatology
|
June 20, 2008
B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses
Hugo Mouquet, Philippe Musette, Marie-Lyse Gougeon, et al.
Transfusion
|
September 4, 2007
Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature
Justyna Kanold, Etienne Merlin, Pascale Halle, et al.
Experimental Dermatology
|
September 3, 2025
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model
Marine Delmas, Benjamin Chaussin, Nathan Harismendy, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 25, 2002
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging
Nicole Moins, Michel D'Incan, Jacques Bonafous, et al.
European Journal of Dermatology : EJD
|
December 31, 2014
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models
Claire Viallard, Yann Perrot, Zied Boudhraa, et al.
Journal of the American Academy of Dermatology
|
January 29, 2022
Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study
Gilles Battesti, Charline Garcia, Manuelle Viguier, et al.
BMC Cancer
|
April 16, 2022
Phase I study of [<sup>131</sup>I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
Emilie Thivat, Jacques Rouanet, Philippe Auzeloux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2010
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients
Delphine Kérob, Raphael Porcher, Olivier Vérola, et al.
Archives of Dermatology
|
June 19, 2008
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome
Gaëlle Quereux, Sonia Marques, Jean-Michel Nguyen, et al.
American Journal of Clinical Pathology
|
January 14, 2011
Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases
Claire Bénet, Aurélie Gomez, Claire Aguilar, et al.
Page
of 8